Chilean weight-loss drug market expands with Wegovy and Mounjaro launches

The Chilean pharmaceutical market is diversifying with the introduction of Wegovy and Mounjaro alongside existing Ozempic supplies and upcoming generic semaglutide versions. This expansion has triggered a national debate regarding equitable access, regulatory oversight, and the clinical prioritization of GLP-1 receptor agonists.